本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sarepta Therapeutics

20.45
-0.0700-0.34%
盤後20.29-0.1600-0.78%19:58 EDT
成交量:181.07萬
成交額:3,722.62萬
市值:21.59億
市盈率:-15.54
高:21.10
開:20.76
低:20.29
收:20.52
52周最高:25.32
52周最低:14.68
股本:1.06億
流通股本:9,905.26萬
量比:0.49
換手率:1.83%
股息:- -
股息率:- -
每股收益(TTM):-1.3161
每股收益(LYR):-7.1300
淨資產收益率:-9.48%
總資產收益率:-1.13%
市淨率:1.41
市盈率(LYR):-2.87

資料載入中...

2024/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/25

關聯方擬減持公告

Form144|賽普拉高管Bilal Arif擬減持3898股,總價約63.9萬美元
2024/06/25

關聯方擬減持公告

Form144|賽普拉高管Ryan Brown擬減持38957股,總價約638萬美元
2024/06/24

關聯方擬減持公告

Form144|賽普拉高管Bilal Arif擬減持7859股,總價約126萬美元
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities